Christer Peterson

Title: Innovations in Diagnostics: The Contributions of Christer Peterson

Introduction

Christer Peterson is a notable inventor based in Storvreta, Sweden. He has made significant contributions to the field of diagnostics, particularly in the detection of molecular forms of eosinophilic cationic protein. His work has implications for medical diagnostics and patient care.

Latest Patents

Christer Peterson holds a patent for a diagnostic method for the detection of molecular forms of eosinophilic cationic protein (ISO-ECPS). This innovative diagnostic method involves measuring the level of at least one iso-eosinophilic cationic protein in a sample from an individual. The measured level is then compared to a predetermined level of the iso-ECP. The iso-ECP is known to be cytotoxic, and its cytotoxicity cannot be neutralized by the monoclonal antibodies EG1 and EG2. The anti-iso-ECP antibody used in this method specifically binds to a cytotoxic isoform of ECP that has a unique epitope for the native form of the cytotoxic iso-ECP.

Career Highlights

Christer Peterson is associated with Pharmacia Diagnostics AB, where he has been instrumental in advancing diagnostic technologies. His work has contributed to the understanding and detection of eosinophilic cationic proteins, which are important in various medical conditions.

Collaborations

One of his notable collaborators is Per Venge, who has worked alongside Peterson in the field of diagnostics. Their combined expertise has led to advancements in the understanding of eosinophilic cationic proteins and their implications in health.

Conclusion

Christer Peterson's innovative work in diagnostic methods highlights the importance of research in improving medical diagnostics. His contributions continue to influence the field and enhance patient care through better detection methods.